Search
In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.
Increased numbers of children presenting with febrile adverse events following trivalent influenza vaccine (TIV) were noted in Australia in 2010.
Males are generally more susceptible to respiratory infections; however, there are few data on the physiological responses to such infections in males and...
We aimed to determine Australian paediatricians' beliefs and practices around the influenza vaccination of children.
Seasonal influenza is an important cause of acute neurological disease in Australian children.
These findings reinforce current recommendations for annual influenza vaccination, particularly those at greatest risk of influenza disease.
NIP has seen poor vaccine impact, related to recent vaccine safety concerns.
We assessed the safety of receiving an influenza vaccination during any trimester of pregnancy with respect to preterm births and infant birthweight.
This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza during the 2015 influenza season
This study aimed to determine whether chronic, low-dose exposure to geogenic particulate matter <10μm diameter (PM10) exacerbates viral infections of the...